Outcome of Patients With Differentiated Thyroid Cancer Treated With 131-Iodine on the Basis of a Detectable Serum Thyroglobulin Level After Initial Treatment

MLA

Leonardo Pace, et al. “Outcome of Patients With Differentiated Thyroid Cancer Treated With 131-Iodine on the Basis of a Detectable Serum Thyroglobulin Level After Initial Treatment.” Frontiers in Endocrinology, vol. 10, Nov. 2018. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....b61bf2c4471467964eab6b47354df2a2&authtype=sso&custid=ns315887.

APA

Leonardo Pace, Emanuela Mazziotti, Giovanni De Simini, Alberto Cuocolo, Simona Limone, Emilia Zampella, Michele Klain, & Teresa Mannarino. (2018). Outcome of Patients With Differentiated Thyroid Cancer Treated With 131-Iodine on the Basis of a Detectable Serum Thyroglobulin Level After Initial Treatment. Frontiers in Endocrinology, 10.

Chicago

Leonardo Pace, Emanuela Mazziotti, Giovanni De Simini, Alberto Cuocolo, Simona Limone, Emilia Zampella, Michele Klain, and Teresa Mannarino. 2018. “Outcome of Patients With Differentiated Thyroid Cancer Treated With 131-Iodine on the Basis of a Detectable Serum Thyroglobulin Level After Initial Treatment.” Frontiers in Endocrinology 10 (November). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....b61bf2c4471467964eab6b47354df2a2&authtype=sso&custid=ns315887.